Immix Biopharma, Inc. IMMX Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s other current assets?
- Immix Biopharma, Inc. (IMMX) reported other current assets of $335.74K in Q1 2026.
- How has Immix Biopharma, Inc.'s other current assets changed year-over-year?
- Immix Biopharma, Inc.'s other current assets increased by 99.4% year-over-year, from $168.4K to $335.74K.
- What is the long-term trend for Immix Biopharma, Inc.'s other current assets?
- Over 3 years (2022 to 2025), Immix Biopharma, Inc.'s other current assets has grown at a 24.5% compound annual growth rate (CAGR), from $78.07K to $150.72K.